What do you understand by the term "Multi-Drug Resistant Tuberculosis" (MDR-TB)? What measures would you advocate for its containment and what are the implications of its spread in the community?
Define MDR-TB precisely, propose concrete containment measures, and explain the medical, social and economic implications of its spread.
Common trap: Many answers give a vague definition. State the exact definition (resistance to at least isoniazid and rifampicin), distinguish XDR-TB, and anchor measures in RNTCP/PMDT and the 2012 notification order.
SyllabusOld-pattern GS Paper I (2006–12): Current events of national importance and topics of social relevance (public health)
Model answer
15 marks · 150-word limitMulti-Drug Resistant Tuberculosis (MDR-TB) is TB caused by bacteria resistant to at least isoniazid and rifampicin, the two most powerful first-line drugs. Extensively drug-resistant TB (XDR-TB) is additionally resistant to fluoroquinolones and an injectable second-line drug. India has the world's largest TB burden.
- Incomplete or wrong treatment
- Resistant bacteria survive
- MDR-TB patient
- Airborne spread to contacts
- Primary MDR-TB in new patients
Containment measures
- Notification: TB was made a notifiable disease in May 2012, bringing private-sector cases into the system.
- Diagnosis: Rapid molecular tests such as line probe assays and GeneXpert; the ban on unreliable serological tests in 2012.
- Treatment: Scale up PMDT (DOTS-Plus) with supervised, free second-line regimens and patient support.
- Rational drug use: Stop over-the-counter sale and irrational prescribing of anti-TB drugs; assure drug quality.
- Infection control and nutrition: Ventilation in hospitals, masks, contact tracing, and nutritional support to improve adherence.
Implications of its spread
- Medical: Treatment lasts about two years with toxic drugs and lower cure rates; cases of so-called 'totally drug-resistant' TB were reported from Mumbai in 2012.
- Economic: High cost, lost wages and catastrophic spending push families into poverty.
- Social: Stigma, HIV co-infection and transmission in crowded slums and prisons.
- Health system: Second-line drugs and laboratory capacity strain the RNTCP budget and undermine the gains of the DOTS strategy since 1997.
(Later: India adopted the National Strategic Plan 2017–25, launched Ni-kshay Poshan Yojana (2018) and shorter bedaquiline-based regimens, aiming at TB elimination.)
Read more — sources
- OfficialRevised National Tuberculosis Control Programme (RNTCP), Guidelines on Programmatic Management of Drug-Resistant TB (PMDT) in India, 2012
- ReportWorld Health Organization, Global Tuberculosis Report 2012
- ReportUdwadia Z.F. et al., 'Totally drug-resistant tuberculosis in India', Clinical Infectious Diseases (2012)
More from GS Paper I (old) 2012
Model answer by the EdiShorts editorial team. It is one well-argued treatment of the question, written to the official word limit — not an official UPSC answer key.